Lucidam

Lucidam appears to be a Tokyo-based private investment firm rather than a drug developer, CRO, or operating biopharma company. Publicly available evidence links Lucidam to healthcare-related investing through a joint venture with ABVC BioPharma via BioLite Japan to identify early-stage opportunities in drug development, digital health, and medical devices in Japan. There is no clear evidence that Lucidam itself develops therapeutic assets, runs a clinical pipeline, or markets healthcare products directly. Based on currently available sources, it is best characterized as a healthcare-focused investment or business development entity with exposure to life sciences opportunities.